|
US4038412A
(en)
|
1975-08-25 |
1977-07-26 |
Richardson-Merrell Inc. |
N-(phenylether-substituted benzyl)alkanediamines
|
|
DE2616484C3
(de)
|
1976-04-14 |
1981-02-26 |
A. Nattermann & Cie Gmbh, 5000 Koeln |
Basische Benzoyläther, deren Salze und quartäre Ammoniumverbindungen sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
CA1118422A
(en)
|
1978-11-20 |
1982-02-16 |
Herbert J. Havera |
Trans-2-substituted-amido-hexahydrobenzo [a] quinolizines
|
|
IL94466A
(en)
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
|
IE903196A1
(en)
|
1989-09-05 |
1991-03-13 |
Searle & Co |
Substituted n-benzylpiperidine amides
|
|
US5212182A
(en)
|
1990-10-03 |
1993-05-18 |
American Home Products Corpooration |
Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
|
|
GB9321812D0
(en)
|
1993-10-22 |
1993-12-15 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5432198A
(en)
|
1994-08-18 |
1995-07-11 |
Sphinx Pharmaceuticals Corporation |
Vicinal-substituted carbocyclic compounds as therapeutic agents
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
US5585492A
(en)
|
1994-10-11 |
1996-12-17 |
G. D. Searle & Co. |
LTA4 Hydrolase inhibitors
|
|
GB9515412D0
(en)
|
1995-07-27 |
1995-09-27 |
Pharmacia Spa |
2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
|
|
AU4020897A
(en)
|
1996-08-17 |
1998-03-06 |
Zeneca Limited |
3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
|
|
US6207665B1
(en)
|
1997-06-12 |
2001-03-27 |
Schering Aktiengesellschaft |
Piperazine derivatives and their use as anti-inflammatory agents
|
|
UA52797C2
(uk)
|
1997-11-20 |
2003-01-15 |
Тейдзін Лімітед |
Похідне біфеніламідину, проліки, інгібітор коагуляції крові, агент для профілактики тромбозу або емболії та агент для терапії тромбозу або емболії
|
|
TR200001962T2
(tr)
|
1997-12-19 |
2001-01-22 |
Novo Nordisk A/S |
Fenol oksitleyen bir enzim yoluyla polisakkaridlerin modifikasyonu
|
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
AU4614100A
(en)
|
1999-05-17 |
2000-12-05 |
Teijin Limited |
Cyanobiphenyl derivatives
|
|
DE60023926T2
(de)
*
|
1999-09-10 |
2006-07-20 |
Merck & Co., Inc. |
Tyrosin kinase inhibitoren
|
|
AU7961100A
(en)
|
1999-10-28 |
2001-05-08 |
Daiichi Pharmaceutical Co., Ltd. |
Drug discharge pump inhibitors
|
|
WO2001049288A1
(en)
|
2000-01-06 |
2001-07-12 |
Merck Frosst Canada & Co. |
Novel compounds and compositions as protease inhibitors
|
|
AU2868601A
(en)
|
2000-01-27 |
2001-08-07 |
Ribotargets Ltd |
Biaryl compounds, their preparation and their use in therapy
|
|
EP1686119B1
(en)
*
|
2000-02-16 |
2009-07-29 |
Smithkline Beecham Plc |
Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
|
|
EP1339702A1
(en)
|
2000-03-15 |
2003-09-03 |
Warner-Lambert Company |
5-amide substituted diarylamines as mek inhibitors
|
|
DE60115227T2
(de)
|
2000-05-11 |
2006-08-24 |
Bristol-Myers Squibb Co. |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
|
US20020032238A1
(en)
|
2000-07-08 |
2002-03-14 |
Henning Priepke |
Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
|
|
HUP0500470A3
(en)
|
2000-09-01 |
2005-11-28 |
Fmc Corp |
1,4-disubstituted benzenes as insecticides and use thereof
|
|
IL154363A0
(en)
|
2000-09-25 |
2003-09-17 |
Actelion Pharmaceuticals Ltd |
Substituted amino-aza-cycloalkanes useful against malaria
|
|
GB0024808D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0024807D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
CN1489575A
(zh)
|
2001-01-29 |
2004-04-14 |
������������ʽ���� |
苯甲脒衍生物及其制备方法
|
|
AR035425A1
(es)
|
2001-01-30 |
2004-05-26 |
Teijin Ltd |
Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo
|
|
EP1372655B1
(en)
|
2001-03-02 |
2008-10-01 |
Merck Frosst Canada Ltd. |
Cathepsin cysteine protease inhibitors
|
|
WO2002083641A2
(en)
|
2001-04-17 |
2002-10-24 |
Actelion Pharmaceuticals Ltd. |
Amino-aza-cyclohexanes for the treatment of malaria
|
|
US20030186963A1
(en)
*
|
2001-09-14 |
2003-10-02 |
Dorwald Florencio Zaragoza |
Substituted piperidines
|
|
EP1430027B1
(en)
|
2001-09-14 |
2010-09-01 |
High Point Pharmaceuticals, LLC |
Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
|
|
WO2003028720A1
(en)
|
2001-09-26 |
2003-04-10 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
AU2002357692A1
(en)
|
2001-11-09 |
2003-05-26 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
|
DE60335979D1
(de)
|
2002-02-13 |
2011-03-24 |
Ppg Ind Ohio Inc |
Rbundbeschichtung auf einem träger
|
|
US6660736B2
(en)
|
2002-03-27 |
2003-12-09 |
Hoffmann-La Roche Inc. |
Phthalimido derivatives and a process for their preparation
|
|
CA2482838A1
(en)
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Pyrazole compounds and pharmaceutical compositions containing the compound
|
|
JP2005194193A
(ja)
|
2002-06-11 |
2005-07-21 |
Taisho Pharmaceut Co Ltd |
ケモカイン受容体拮抗化合物
|
|
US20060063782A1
(en)
|
2002-07-03 |
2006-03-23 |
Murray Christopher W |
3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
|
EP1541558B1
(en)
|
2002-08-13 |
2008-08-13 |
Shionogi & Co., Ltd. |
Heterocyclic compounds having hiv integrase inhibitory activity
|
|
CA2851462A1
(en)
|
2003-01-08 |
2004-07-29 |
University Of Washington |
Antibacterial agents
|
|
CA2517256C
(en)
|
2003-02-26 |
2013-04-30 |
Sugen, Inc. |
Aminoheteroaryl compounds as protein kinase inhibitors
|
|
WO2004081005A1
(en)
*
|
2003-03-07 |
2004-09-23 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
US7232825B2
(en)
|
2003-05-02 |
2007-06-19 |
Guoqing P Chen |
Phenylaminopyrimidine derivatives and methods of use
|
|
CA2530816A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Bayer Healthcare Ag |
Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases
|
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
|
WO2005012270A2
(en)
|
2003-07-29 |
2005-02-10 |
Rib-X Pharmaceuticals, Inc. |
Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
|
|
US7094791B2
(en)
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
|
US7572816B2
(en)
|
2003-08-01 |
2009-08-11 |
Auspex Pharmaceuticals, Inc. |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
|
|
JP2007513082A
(ja)
|
2003-11-10 |
2007-05-24 |
シエーリング アクチエンゲゼルシャフト |
Ccr−5アンタゴニストとして有用なベンジルエーテルアミン化合物
|
|
EP1535908A1
(en)
|
2003-11-24 |
2005-06-01 |
Newron Pharmaceuticals S.p.A. |
N-acyl-N'-benzyl-alkylendiamino drivatives
|
|
BRPI0418351A
(pt)
|
2004-01-05 |
2007-05-08 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
|
|
US20090253908A1
(en)
|
2004-03-11 |
2009-10-08 |
Glaxo Group Limited |
Novel m3 muscarinic acetylchoine receptor antagonists
|
|
SE0401342D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds
|
|
WO2006028029A1
(ja)
|
2004-09-07 |
2006-03-16 |
Sankyo Company, Limited |
置換ビフェニル誘導体
|
|
US7932247B2
(en)
|
2004-11-15 |
2011-04-26 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
ES2339138T3
(es)
|
2004-11-24 |
2010-05-17 |
Eli Lilly And Company |
Derivados de eteres aromaticos utiles como inhibidores de la trombina.
|
|
DE102004061008A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one
|
|
DE102004061006A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Benzylthio-1,2,4-triazin-5(2H)-one
|
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
NZ560969A
(en)
|
2005-02-17 |
2010-08-27 |
Albany Molecular Res Inc |
Benzoxazole carboxamides for treating chemotherapy-induced vomiting and irritable bowel syndrome
|
|
US20070078172A1
(en)
|
2005-06-16 |
2007-04-05 |
Jenrin Discovery |
Mao-b inhibitors useful for treating obesity
|
|
US20070015832A1
(en)
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
CA2625638C
(en)
|
2005-11-08 |
2014-03-11 |
Surmodics, Inc. |
Ultra-thin photo-polymer coatings and uses thereof
|
|
WO2007079078A1
(en)
*
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
ITMI20060179A1
(it)
|
2006-02-02 |
2007-08-03 |
Abiogen Pharma Spa |
Procedimento per la risoluzione di miscele racemiche e complesso diastereoisomerico di un agente risolvente e di unantiomero di interesse
|
|
CA2646076C
(en)
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
TW200808705A
(en)
|
2006-06-15 |
2008-02-16 |
Sanofi Aventis |
Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
|
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
|
EP2102158A1
(en)
|
2006-12-11 |
2009-09-23 |
Topo Target A/S |
Prodrugs of diphenyl ox- indol- 2 -one compounds for the treatment of cancers
|
|
CL2007003874A1
(es)
|
2007-01-03 |
2008-05-16 |
Boehringer Ingelheim Int |
Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
|
|
SA08280783B1
(ar)
|
2007-01-11 |
2011-04-24 |
استرازينيكا ايه بي |
مشتقات بيريدوبيريميدين كمثبطات pde4
|
|
CA2674865A1
(en)
|
2007-01-15 |
2008-07-24 |
Santen Pharmaceutical Co., Ltd. |
Indole derivative having i.kappa.b kinase .beta. inhibitory activity
|
|
US20080200454A1
(en)
|
2007-02-15 |
2008-08-21 |
Ameriks Michael K |
Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
WO2008101195A2
(en)
|
2007-02-16 |
2008-08-21 |
Othera Holding, Inc. |
Drug resistance reversal in neoplastic disease
|
|
EP2620429A1
(en)
|
2007-02-22 |
2013-07-31 |
Colby Pharmaceutical Company |
Hydroxylamine compounds and methods of their use
|
|
JP2010120852A
(ja)
|
2007-03-09 |
2010-06-03 |
Daiichi Sankyo Co Ltd |
新規なジアミド誘導体
|
|
US20100256147A1
(en)
*
|
2007-04-13 |
2010-10-07 |
Hangauer Jr David G |
Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
|
|
EP3103791B1
(en)
*
|
2007-06-27 |
2018-01-31 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
PE20090837A1
(es)
|
2007-07-02 |
2009-07-24 |
Boehringer Ingelheim Int |
Nuevos compuestos quimicos
|
|
AU2008311375A1
(en)
|
2007-10-10 |
2009-04-16 |
Merck Sharp & Dohme Corp. |
Diphenyl substituted cycloalkanes
|
|
US7932279B2
(en)
|
2007-10-12 |
2011-04-26 |
Arqule, Inc. |
Substituted tetrazole compounds and uses thereof
|
|
BRPI0821026A2
(pt)
|
2007-12-19 |
2015-06-16 |
Newron Pharmaceutical S P A |
Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
|
|
US20120009151A1
(en)
*
|
2007-12-21 |
2012-01-12 |
Progenics Pharmaceuticals, Inc. |
Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof
|
|
AR070563A1
(es)
|
2008-02-06 |
2010-04-21 |
Glaxo Group Ltd |
Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.
|
|
PE20091553A1
(es)
|
2008-02-06 |
2009-10-30 |
Glaxo Group Ltd |
Farmacoforos duales - antagonistas muscarinicos de pde4
|
|
MY150379A
(en)
|
2008-02-26 |
2013-12-31 |
Takeda Pharmaceutical |
Fused heterocyclic derivative and use thereof
|
|
WO2009130469A1
(en)
|
2008-04-25 |
2009-10-29 |
Kudos Pharmaceuticals Limited |
Dna-pk inhibitors
|
|
WO2009136625A1
(ja)
*
|
2008-05-07 |
2009-11-12 |
大日本住友製薬株式会社 |
環状アミン-1-カルボン酸エステル誘導体およびそれを含有する医薬組成物
|
|
US20100035862A1
(en)
|
2008-06-25 |
2010-02-11 |
Abbott Laboratories |
Novel aza-cyclic indole-2-carboxamides and methods of use thereof
|
|
WO2010033643A2
(en)
|
2008-09-17 |
2010-03-25 |
Burnham Institute For Medical Research |
Small molecule compounds for stem cell differentiation
|
|
US9238657B2
(en)
|
2008-10-31 |
2016-01-19 |
Shionogi & Co., Ltd. |
Cephalosporin having catechol group
|
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
|
WO2010111353A1
(en)
|
2009-03-25 |
2010-09-30 |
Acadia Pharmaceuticals, Inc. |
N-substituted piperidine derivatives as serotonin receptor agents
|
|
WO2010141817A1
(en)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
|
PL2470173T3
(pl)
|
2009-08-25 |
2016-11-30 |
|
Leczenie skojarzone nanocząstkowymi kompozycjami taksanu i inhibitorów hedgehog
|
|
JP5781527B2
(ja)
*
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ.ベー. |
4−置換−2−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
TWI503323B
(zh)
|
2010-03-29 |
2015-10-11 |
Oncotherapy Science Inc |
三環化合物以及含此化合物之pbk抑制劑
|
|
KR20130018845A
(ko)
|
2010-04-05 |
2013-02-25 |
시오노기세야쿠 가부시키가이샤 |
카테콜기를 갖는 세펨 화합물
|
|
JP5823514B2
(ja)
|
2010-07-07 |
2015-11-25 |
アーデリクス,インコーポレーテッド |
リン酸輸送を阻害する化合物及び方法
|
|
WO2012006475A1
(en)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
AR082498A1
(es)
|
2010-08-20 |
2012-12-12 |
Gruenenthal Gmbh |
Derivados ciclicos de carboxamida y urea sustituidos como ligandos del receptor de vainiloide
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
US8722076B2
(en)
|
2010-09-30 |
2014-05-13 |
Surmodics, Inc. |
Photochrome- or near IR dye-coupled polymeric matrices for medical articles
|
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
WO2012079154A1
(en)
|
2010-12-14 |
2012-06-21 |
Dalhousie University |
Selective estrogen receptor modulators
|
|
CA2836202A1
(en)
|
2011-05-30 |
2012-12-06 |
Astellas Pharma Inc. |
Imidazopyridine compounds
|
|
JP2013047223A
(ja)
*
|
2011-07-28 |
2013-03-07 |
Otsuka Pharmaceut Co Ltd |
医薬
|
|
GB201118876D0
(en)
*
|
2011-11-01 |
2011-12-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
TW201329025A
(zh)
*
|
2011-11-01 |
2013-07-16 |
Astex Therapeutics Ltd |
醫藥化合物
|
|
CA2853833A1
(en)
|
2011-11-08 |
2013-05-16 |
Arena Pharmaceuticals, Inc. |
Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
|
|
ES2668841T3
(es)
|
2011-11-29 |
2018-05-22 |
Vivozon Inc. |
Derivado novedoso de benzamida y uso del mismo
|
|
CN103130791B
(zh)
|
2011-11-30 |
2016-05-04 |
正大天晴药业集团股份有限公司 |
一种新型苯甲酰胺类化合物
|
|
JP2013112657A
(ja)
|
2011-11-30 |
2013-06-10 |
Toray Ind Inc |
フェノキシメチルベンズアミド誘導体、その薬学的に許容される酸付加塩及びその医薬用途
|
|
CN105030750B
(zh)
|
2011-12-23 |
2018-08-28 |
中国医学科学院医药生物技术研究所 |
一组木豆素结构类似化合物在抗丙肝病毒和抗艾滋病毒的应用
|
|
RS54539B1
(sr)
|
2012-02-21 |
2016-06-30 |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. |
Upotreba 1h-indazol-3-karboksamidnih jedinjenja kao inhibitora kinaze 3-beta glikogen sintetaze
|
|
WO2013151991A1
(en)
|
2012-04-02 |
2013-10-10 |
Surmodics, Inc. |
Hydrophilic polymeric coatings for medical articles with visualization moiety
|
|
UY35103A
(es)
|
2012-10-29 |
2014-05-30 |
Glaxo Group Ltd |
Compuestos de cefem 2-sustituidos
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US9321764B2
(en)
|
2013-03-12 |
2016-04-26 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone inhibitors
|
|
CA2913162C
(en)
|
2013-05-22 |
2021-07-27 |
Curza Global, Llc |
Compositions and methods comprising a polyamine
|
|
US9914740B2
(en)
|
2013-07-02 |
2018-03-13 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
US9422285B2
(en)
|
2013-08-08 |
2016-08-23 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof
|
|
JP6417419B2
(ja)
|
2013-09-04 |
2018-11-07 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
免疫調節剤として有用な化合物
|
|
EP2857388A1
(de)
*
|
2013-10-01 |
2015-04-08 |
Grünenthal GmbH |
Sulfon-haltige Azole
|
|
US9458150B2
(en)
*
|
2013-11-08 |
2016-10-04 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
HK1244211A1
(zh)
|
2014-11-14 |
2018-08-03 |
Melinta Therapeutics, Inc. |
治疗、预防或降低皮肤感染风险的方法
|